Overcoming Obstacles to Maximize Patient Enrollment

Discover how Ergomed transforms challenges into achievements in oncology trials.

 
Our latest case study highlights a Phase II Study in Gynecologic Oncology, focusing on recurrent, platinum-sensitive cancers such as high-grade epithelial ovarian, primary peritoneal, and fallopian tube cancers. With stringent eligibility requirements and tight timelines, this trial faced significant hurdles in patient enrollment and country-specific approval delays. See how Ergomed’s Study Physician Service (SPS) fostered strong site relationships, strategic support, and tailored inclusion plans, accelerating patient enrollment and surpassing trial targets. Download the full case study to learn how Ergomed empowers oncology research success.
 

"*" indicates required fields

Please enter your details to get access to the resource

By submitting this form, you consent to your personal data submitted in the form being processed in alignment with our Online Privacy and Cookies policy. Your personal data will be processed to facilitate your request and may be used for sending you additional marketing and business development-related information about Ergomed, its affiliates, and our services. You can withdraw your consent anytime by messaging marketing@ergomedgroup.com, and we will promptly remove your data from our records. For more information about how we will process your personal data and your rights, please see our Online Privacy and Cookies policy.
This field is for validation purposes and should be left unchanged.